Differential neutralizing antibody responses to varicella-zoster virus glycoproteins B and E following naked DNA immunization

Viral Immunology

Volumn 12, Issue 3, 1999, Pages 227-236

  Massaer, Marc ^a   Haumont, Michele ^a   Garcia, Lida ^a   Mazzu, Lina ^a   Bollen, Alex ^a   Jacobs, Paul ^a   Jacquet, Alain ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; NUCLEIC ACID; VIRUS GLYCOPROTEIN;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VARICELLA ZOSTER VIRUS;

ANIMALIA; HUMAN HERPESVIRUS 3;

EID: 0032876484     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1999.12.227     Document Type: Article

References (29)

1. Arvin, A.M., J.F. Moffat, and R. Redman. 1996. Varicella Zoster Virus: Aspects of pathogenesis and host response to natural infection and Varicella vaccine: Adv. Virus Res. 40:263-309.
2. Bourne, N., L.R. Stanberry, D.I. Bernstein, and D. Lew. 1996. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:800-807.
3. Cardoso, A.I., M. Blixenkrone-Moller, J. Fayolle, M. Liu, R. Buckland, and T.F. Wild. 1996. Immunization with plasmid DNA encoding for the measle virus haemagluttinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology. 225:293-299.
4. Chow, Y.H., W.L. Huang, W.C. Chi, Y.D. Chu, and M.-H. Tao. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids co-expressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169-178.
5. Davison, A.J., and J.E. Scott. 1986. The complete DNA sequence of Varicella-Zoster Virus. J. Gen. Virol. 67:1759-1816.
6. Edson, C.M., B.A. Hosler, R.A. Respess, D.J. Waters, and D.A. Thorley-Lawson. 1985. Cross-reactivity between herpes simplex virus glycoprotein B and a 63000 Dalton varicella-zoster virus envelope glycoprotein. J. Virol. 56:333-336.
7. Gerdts, V., A. Jöns, B. Makoschey, N. Visser, and T.C. Mettenleiter. 1997. Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen. Virol. 78:2139-2146.
8. Gershon, A.A., S.P. Steinberg, P. LaRussa, A. Ferrara, M. Hammerschlag, and L. Gelb. 1988. Immunization of healthy adults with live attenuated varicella vaccine. J. Infect. Dis. 158:132-137.
9. Ghiasi, H., S. Cai, S. Slanina, A.B. Nesburn, and S.L. Wechsler. 1995. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-2 challenge. Antiviral Res. 28:147-157.
10. Grose, C., D.P. Edwards, K.A. Weigle, W.E. Friedrichs, and W.L. McGuire. 1984. Varicella-Zoster virus specific gp140: A highly immunogenic and disulfide-linked structural glycoprotein. Virology. 132:138-146.
11. Grose, C., and V. Litwin. 1988. Immunology of the varicella-zoster virus glycoproteins. J. Infect. Dis. 157:877-881.
12. Hardy, I.B., A.A. Gershon, P.S. La Russa, and S.P. Steinberg. 1991. The incidence of zoster after immunization with live attenuated varicella vaccine. N. Engl. J. Med. 325:1545-1550.
13. Haumont, M., A. Jacquet, M. Massaer, V. Deleersnyder, P. Mazzu, A. Bollen, and P. Jacobs. 1996. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells. Virus. Res. 40:199-204.
14. Haumont, M., M. Jurdan, H. Kangro, A. Jacquet, M. Massaer, V. Deleersnyder, L. Garcia, A. Bosseloir, C. Bruck, A. Bollen, and P. Jacobs. 1997. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization. J. Med. Virol. 53:63-68.
15. Jacquet, A., M. Massaer, M. Haumont, S. Houard, V. Deleersnyder, M. Place, A. Bollen, and P. Jacobs. 1995. Purification and characterization of recombinant varicella-zoster virus glycoprotein gpII, secreted by Chinese hamster ovary cells. Protein. Expr. Purif. 6:91-98.
16. Kirnbauer, R., F. Booy, N. Cheng, D.R. Lowy, and J.T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA. 89:12180-12184.
17. Lewis, P.J. G.J.M. Cox, S. van Drunen Littel-van der Hurk, and L.A. Babiuk. 1997. Polynucleotide vaccines in animals: Enhancing and modulating response. Vaccine. 15:861-864.
18. Manickan, E., K.L. Karem, and B.T. Rouse. 1997. DNA vaccines - A modern gimmick or a boon to vaccinology. Critic. Rev. In Immunol. 17:139-154.
19. Manickan, E., R.J. Rouse, Z. Yu, W.S. Wire, and B.T. Rouse. 1995. Genetic immunization against herpes simplex virus J. Immunol. 155:259-265.
20. Manickan, E., Z. Yu, R.J.D. Rouse, W.S. Wire, and B.T. Rouse. 1995. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate-early protein ICP27. Viral Immunology. 8:53-61.
21. Massaer, M., M. Haumont, M. Place, A. Bollen, and P. Jacobs. 1993. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus. J. Gen. Virol. 74:491-494.
22. Nader, S., R. Bergen, M. Sharp, and A.M. Arvin. 1995. Age-related differences in cell mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 171:13-17.
23. Nass, P.H., K.L. Elkins, and J.P. Weir. 1998. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins. J. Infect. Dis. 178:611-617.
24. Peters, B.S., R. Cheingsong-Popov, D. Callow, R. Foxall, G. Patou, K. Hodgkin, K., and J.N. Weber. 1997. A pilot phase II study of the saety and immunogenicity of HTV p17/p24:VLP (p24-VLP) in asymptomatic HTV seropositive subjects. J. Infect. 35:231-235.
25. Ulrich, R., M. Nassal, H. Meisel, and D.H. Kruger. 1998. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus. Res. 50:141-182.
26. Vafai, A., K. Jensen, K., and R. Kubo. 1989. Existence of similar antigenic sites on varicella-zoster virus gpI and gpIV. Virus. Res. 13:319-336.
27. Van Drunen Little-van den Hurk, S., R.P. Braun, P.J. Lewis, B.C. Karnoven, B.C., M.E. Baca-Estrada, M. Snider, D. McCartney, T. Watts, and L.A. Babiuk. 1998. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79:831-839.
28. Wagner, R., V.J. Teeuwsen, L. Demi, F. Notka, A.G. Haaksma, S.S., Jhagjhoorsingh, H. Niphuis, H. Wolf, and J.L. Heeney. 1998. Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. Virology. 245:65-74.
29. Wu, L., and B. Forghani. 1997. Characterization of neutralizing domains on varicella-zoster virus glycoprotein E defined by monoclonal antibodies. Arch. Virol. 142:349-362.